Breastfeeding Counseling Training on Breast Milk Perception and Baby Feeding Attitudes (EFFBCTBP)

June 27, 2024 updated by: Hatice Gul OZTAS, Kahramanmaras Sutcu Imam University

The Effect of Face-to-Face Breastfeeding Counseling Training on Breast Milk Perception

This research will be conducted to determine the effect of face-to-face breastfeeding counseling training on breast milk perception and infant nutrition attitudes.The population of this semi-experimental research consisted of students who took the Breastfeeding Consultancy course at Kahramanmaraş Sütçü İmam University Faculty of Health Sciences (n=49) and 3rd year students who did not take this course at İnönü University Faculty of Health Sciences (n=47). "Personal Introduction Form", "Adults' Perception Scale on Breast Milk (ASAÖ)" and "Infant Nutrition Attitude Scale (IOWA)" will be used to collect pre-test and post-test data. Pretest data were obtained in the first lesson of the semester in both groups. Participants in the experimental group were given training consisting of breastfeeding counseling course content for 14 weeks. The control group was not given any training on this subject. At the end of the semester, post-test measurements will be made to both groups simultaneously and with the same measurement tools.

Study Overview

Status

Status

Indicates the current recruitment status or the expanded access status.
Not yet recruiting

Conditions

Conditions

The disease, disorder, syndrome, illness, or injury that is being studied. On ClinicalTrials.gov, conditions may also include other health-related issues, such as lifespan, quality of life, and health risks.

Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.

Detailed Description

The rich nutrients contained in breast milk ensure the survival and healthy growth of the newborn . Apart from being a nutrient for the mother and the newborn, breast milk and breastfeeding have many benefits in terms of psychological, social development, immune system, developmental, spiritual, social and financial benefits . It is recommended that the baby should not be breastfed without additional food for the first 6 months . However, although the rate of breastfeeding in Turkey is 98%, the rate of babies being fed only breast milk for the first 6 months is reported to be 41% in the Turkey Population and Health Survey (TDHS)-2018 report. It is very important that breastfeeding begins and continues successfully. However, the breastfeeding process can be affected by many factors related to mother and baby. The mother may not be able to cope alone with some challenging factors such as breast rejection, frequent crying, dissatisfaction after breastfeeding, small amounts of defecation, and insufficient breast milk. In case of possible or real problems with breastfeeding, breastfeeding counseling is required . Providing breastfeeding education and counseling is one of the most important roles and responsibilities of midwives during pregnancy, birth and postpartum . The breastfeeding support that the mother receives from midwives greatly affects breastfeeding decisions. Effective breastfeeding support increases breastfeeding duration and success . Midwifery students are given training on breast milk and breastfeeding in accordance with the Midwifery National Core Education Program (EUÇEP). The purpose of breastfeeding counseling training is to train people to evaluate and manage breastfeeding problems . During the breastfeeding consultancy process; The aim is to support mothers in breastfeeding, to reveal the causes of breast milk insufficiency and to implement practices to increase breast milk However, it has been emphasized in the literature that midwives' breastfeeding counseling is not at the desired level . Breastfeeding counseling course is not included in the curriculum of midwifery departments of every university in Turkey . Studies have also shown that mothers are not always satisfied with the breastfeeding support they receive from midwives after birth A quality education based on evidence-based breastfeeding counseling is required for midwives and midwifery students to provide effective breastfeeding support to breastfeeding women tfeeding is effective in successfully maintaining the self-efficacy and breastfeeding behavior of mothers during the lactation process . It is thought that with this research, the curriculum of the midwifery department of the breastfeeding counseling course will be reviewed and will contribute positively to the increase in breastfeeding rates in our country in the future. The purpose of this research is to determine the effect of breastfeeding counseling training on midwifery students' perception of breast milk and infant feeding attitudes.

Study Type

Study Type

Describes the nature of a clinical study. Study types include interventional studies (also called clinical trials), observational studies (including patient registries), and expanded access.
Interventional

Enrollment (Estimated)

Enrollment

The number of participants in a clinical study. The "anticipated" enrollment is the target number of participants that the researchers need for the study.
98

Phase

Phase

The stage of a clinical trial studying a drug or biological product, based on definitions developed by the U.S. Food and Drug Administration (FDA). The phase is based on the study's objective, the number of participants, and other characteristics. There are five phases: Early Phase 1 (formerly listed as Phase 0), Phase 1, Phase 2, Phase 3, and Phase 4. Not Applicable is used to describe trials without FDA-defined phases, including trials of devices or behavioral interventions.
  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact

The name and contact information for the person who can answer enrollment questions for a clinical study. Each location where the study is being conducted may also have a specific contact, who may be better able to answer those questions.

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Eligibility Criteria

The key requirements that people who want to participate in a clinical study must meet or the characteristics they must have. Eligibility criteria consist of both inclusion criteria (which are required for a person to participate in the study) and exclusion criteria (which prevent a person from participating). Types of eligibility criteria include whether a study accepts healthy volunteers, has age or age group requirements, or is limited by sex.

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • being a midwifery student no communication problems Healthy Volunteers

Exclusion Criteria:

  • communication problems

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm

Participant Group / Arm

A group or subgroup of participants in a clinical trial that receives a specific intervention/treatment, or no intervention, according to the trial's protocol.
Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.
Experimental: education
The pre-test data from the students in the experimental group were collected in the first lesson via the Google form created using the "Personal Introduction Form", "Adults' Perception Scale on Breast Milk (ASAÖ)" and "Iowa Infant Nutrition Attitude Scale (IOWA)", and the first and The second will be sent to the students by the authors. The first question was asked, "Are you willing to participate in this research?" Those who say yes will read and fill out this form themselves. At the end of the 14-week course period, post-test data will be obtained using the same method.
Other: education
breastfeeding consultant training
Other Names:
  • other
No Intervention: control group
640 / 5.000 The pre-test data from the students in the control group is a survey form created by the third author using the "Personal Introduction Form", "Adults' Perception Scale on Mother's Milk (ASAÖ)" and "Infant Nutrition Attitude Scale (IOWA)" before a suitable lesson in the first week of the semester. The form link will be created and sent to the students by the third author via WhatsApp messaging application. The first question was asked, "Are you willing to participate in this research?" Those who say yes will read and fill out this form themselves. At the end of the 14-week course period, the post-test data will be obtained by the third author using the same method.

What is the study measuring?

Primary Outcome Measures

Primary Outcome Measures

In a clinical study's protocol, the planned outcome measure that is the most important for evaluating the effect of an intervention/treatment. Most clinical studies have one primary outcome measure, but some have more than one.
Outcome Measure
Measure Description
Time Frame
First Measurement: 1.602 / 5.000 First Measurement:Adult Perception Scale on Breast Milk
Time Frame: 3 MONTH
Adults' Perception Scale on Breast Milk is a five-point Likert-type, one-dimensional scale consisting of 30 items. The minimum total score to be obtained from the scale is 30 and the maximum is 150 points. As adults' ASAS score increases, it shows that their perception of breast milk is at a good level. C
3 MONTH
Second Measurement:Baby Nutrition Attitude Scale (IOWA)
Time Frame: 3 month
Baby Nutrition Attitude Scale is a scale created by De La Moraave Russell (1999) to predict participants' attitudes towards breastfeeding and the duration of breastfeeding (De La Mora,2019). The scale consists of 17 items and is a 5-point Likert type scale. 8 items in the scale are about formula feeding, and 9 items are about breastfeeding. Scoring of items related to formula nutrition is done by reverse scoring. The total score to be received varies between 17 and 85, and a low score indicates that the participant has a positive attitude towards bottle feeding, and a high score indicates that the participant has a positive attitude towards breastfeeding.
3 month

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Sponsor

The organization or person who initiates the study and who has authority and control over the study.
Kahramanmaras Sutcu Imam University

Collaborators

Collaborators

An organization other than the sponsor that provides support for a clinical study. This support may include activities related to funding, design, implementation, data analysis, or reporting.
Inonu University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

Study Start

The actual date on which the first participant was enrolled in a clinical study. The "anticipated" study start date is the date that the researchers think will be the study start date.
July 15, 2024

Primary Completion (Estimated)

Primary Completion

The date on which the last participant in a clinical study was examined or received an intervention to collect final data for the primary outcome measure. Whether the clinical study ended according to the protocol or was terminated does not affect this date. For clinical studies with more than one primary outcome measure with different completion dates, this term refers to the date on which data collection is completed for all the primary outcome measures. The "anticipated" primary completion date is the date that the researchers think will be the primary completion date for the study.
September 30, 2024

Study Completion (Estimated)

Study Completion

The date on which the last participant in a clinical study was examined or received an intervention/treatment to collect final data for the primary outcome measures, secondary outcome measures, and adverse events (that is, the last participant's last visit). The "anticipated" study completion date is the date that the researchers think will be the study completion date.
October 30, 2024

Study Registration Dates

First Submitted

First Submitted

The date on which the study sponsor or investigator first submitted a study record to ClinicalTrials.gov. There is typically a delay of a few days between the first submitted date and the record's availability on ClinicalTrials.gov (the first posted date).
June 20, 2024

First Submitted That Met QC Criteria

First Submitted That Met QC Criteria

The date on which the study sponsor or investigator first submits a study record that is consistent with National Library of Medicine (NLM) quality control (QC) review criteria. The sponsor or investigator may need to revise and submit a study record one or more times before NLM's QC review criteria are met. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
June 27, 2024

First Posted (Actual)

First Posted

The date on which the study record was first available on ClinicalTrials.gov after National Library of Medicine (NLM) quality control (QC) review has concluded. There is typically a delay of a few days between the date the study sponsor or investigator submitted the study record and the first posted date.
July 3, 2024

Study Record Updates

Last Update Posted (Actual)

Last Update Posted

The most recent date on which changes to a study record were made available on ClinicalTrials.gov. There may be a delay between when the changes were submitted to ClinicalTrials.gov by the study's sponsor or investigator (the last update submitted date) and the last update posted date.
July 3, 2024

Last Update Submitted That Met QC Criteria

Last Update Submitted That Met QC Criteria

The most recent date on which the study sponsor or investigator submitted changes to a study record that are consistent with National Library of Medicine (NLM) quality control (QC) review criteria. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
June 27, 2024

Last Verified

Last Verified

The most recent date on which the study sponsor or investigator confirmed the information about a clinical study on ClinicalTrials.gov as accurate and current. If a study with a recruitment status of recruiting; not yet recruiting; or active, not recruiting has not been confirmed within the past 2 years, the study's recruitment status is shown as unknown.
June 1, 2024

More Information

Terms related to this study

Other Study ID Numbers

Other Study ID Numbers

Identifiers or ID numbers other than the NCT number that are assigned to a clinical study by the study's sponsor, funders, or others. These numbers may include unique identifiers from other trial registries and National Institutes of Health grant numbers.
  • KahramanmaraşSIU3

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Cookie Settings

We use cookies to ensure that we give you the best experience on our website. For more details carefully read our Privacy and Cookies Policy. ...>>>You can change your preferences or withdraw your consent at any time by deleting the cookies from your website or computer as described in the policy. Please accept it and choose your preferences by ticking the corresponding boxes in the "Manage Settings" section below. Please carefully read our Terms of Service before you proceed with using any part of this website.
«Manage Settings